Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder
This study has been completed.
Study NCT00555139   Information provided by GlaxoSmithKline
First Received: November 5, 2007   Last Updated: October 15, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Social Anxiety Disorder
Additional conditions recognized in this trial
Anxiety Disorders
Disease
Phobic Disorders
More general conditions related to this trial
Mental Disorders
Pathologic Processes
Interventions listed in this trial
GSK561679
GW876008
alprazolam
Additional drug interventions recognized in this trial
Anti-Anxiety Agents
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Modulators
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services